Stem Cell Therapy in Horses: Evidence, Risks and Realistic Expectations

Stem cell therapy can be useful in selected equine injuries, but it should never replace diagnosis, imaging, rehabilitation, or honest prognosis.

By Dr Duncan Houston

Stem cell treatment sounds like the perfect modern veterinary solution.

A horse tears a tendon, injures a ligament, develops arthritis, or has a joint that will not settle. Stem cells are injected. Damaged tissue regenerates. The horse returns to work. Everyone lives happily ever after.

Unfortunately, biology is rarely that tidy.

Stem cell therapy is one of the most exciting areas of equine regenerative medicine, but it is also one of the easiest to overmarket. Some horses genuinely appear to benefit, especially in selected tendon and ligament injuries. Other cases are much less clear. Sometimes the horse improves because of the stem cells. Sometimes the horse improves because of rest, controlled loading, farriery, time, shockwave, PRP, or a very good rehabilitation plan happening alongside the injection.

The right question is not “do stem cells work?” The better question is: for this horse, this injury, this tissue, this timing, this product, and this rehab plan, are stem cells actually worth considering?

Quick Answer

Stem cell therapy in horses may help selected tendon, ligament, and joint conditions, but it is not a guaranteed cure and it is not suitable for every injury. The strongest equine evidence is generally around selected superficial digital flexor tendon injuries and some soft tissue injuries, where stem cell-based approaches may improve healing quality and reduce reinjury risk, although high-quality randomised clinical trials are still limited. Evidence for osteoarthritis is developing, with weak to moderate support for short-term lameness improvement in some mild to moderate cases, but it is not proven to be clearly superior to standard joint treatments such as corticosteroids. Stem cells should be considered only after a proper diagnosis, imaging, prognosis discussion, and rehabilitation plan. (Veterinary Evidence)

What Are Stem Cells?

Stem cells are cells with the ability to divide and influence tissue repair. In equine medicine, most treatments marketed as “stem cell therapy” involve mesenchymal stromal or stem cells, often shortened to MSCs.

These cells may be collected from:

• Bone marrow

• Fat tissue

• Blood-derived or peripheral blood sources

• Umbilical cord blood or tissue

• Donor horses in allogeneic products

The FDA describes animal cell and tissue products as products derived from cells or tissues that are administered to an animal recipient, and gives examples including animal stem cells, differentiated cells, blood-derived products, platelet-rich plasma, and amnion. It also notes that common tissues used to create stem cell or related products include blood, fat, and bone marrow. (U.S. Food and Drug Administration)

In simple terms, stem cell therapy is not one single treatment. A bone marrow-derived autologous product, an adipose-derived product, an allogeneic donor cell product, and a tenogenic-primed cell product are not automatically the same thing.

That matters because marketing often talks about “stem cells” as if all products behave identically.

They do not.

How Do Stem Cells Actually Help?

The old simple explanation was: stem cells turn into new tendon, ligament, cartilage, or bone.

The more realistic explanation is more nuanced.

In many cases, MSCs probably help by influencing the local healing environment. They may modulate inflammation, release signalling molecules, influence immune responses, and support a better organised repair process. The Royal Veterinary College states that the mechanism is not completely clarified, but the strongest evidence points more toward modulation of the inflammatory process than true regeneration. (Royal Veterinary College)

That is important because owners often imagine stem cells rebuilding a perfect new tendon or cartilage surface.

A better expectation is:

Stem cells may help guide repair. They do not automatically replace damaged tissue with brand-new, perfect tissue.

That is less flashy, but much closer to the truth.

What Conditions Are Stem Cells Used For in Horses?

Stem cell therapies are most often considered for:

• Superficial digital flexor tendon injuries

• Suspensory ligament injuries

• Other selected ligament lesions

• Meniscal or joint-associated soft tissue injuries in selected cases

• Mild to moderate osteoarthritis in selected cases

• Focal cartilage or joint disease in selected cases

• Some wound healing or experimental applications

• Research settings for neurological or spinal conditions

The most common real-world use is still musculoskeletal injury, especially tendon and ligament injury.

But this does not mean every tendon, ligament, or joint problem should receive stem cells. A mild tendon strain, chronic severe arthritis, undiagnosed lameness, septic joint, fracture, or advanced degenerative disease may require a completely different plan.

Where Is the Evidence Strongest?

The best-supported area is selected tendon injury, especially superficial digital flexor tendon injury.

A Veterinary Evidence review concluded that experimental evidence suggests intralesional stem cell treatment can improve histological characteristics and matrix organisation in healing equine superficial digital flexor tendons. It also found case-based evidence suggesting improved tendon healing quality and reduced recurrence, but warned that the lack of randomised, controlled prospective studies with function-based outcomes remains concerning given the widespread use of these therapies. (Veterinary Evidence)

The Royal Veterinary College reports that stem cell-based treatments have shown improved outcomes compared with conventional tendon treatments by reducing reinjury rates in racehorses and sports horses, but it also states that full proof would require large randomised controlled trials. (Royal Veterinary College)

That is the balanced view:

• There is meaningful promise.

• There is more evidence for some tendon cases than many other uses.

• The evidence is not perfect.

• Rehab remains essential.

What About Tendon and Ligament Injuries?

Tendon and ligament injuries are attractive targets for stem cell therapy because they often heal with scar tissue that is less elastic and less organised than normal tendon or ligament. That inferior repair tissue can increase reinjury risk.

A 2-year follow-up study of horses treated with tenogenically induced allogeneic MSCs in platelet-rich plasma reported that, after 12 months, 83.8% of suspensory ligament cases and 79.2% of superficial digital flexor tendon cases returned to previous performance level. At 24 months, 82.4% of suspensory ligament cases and 85.7% of superficial digital flexor tendon cases had returned to previous level. The same study reported lower reinjury rates in the treated group compared with published conventional-treatment data, but also acknowledged the limitations of non-blinded clinical data and literature-based comparisons. (PMC)

That is promising, especially for injuries where reinjury risk is the big enemy.

But the key words are selected cases.

Stem cells are not equally justified for every swollen leg.

A good candidate usually needs:

• A confirmed tendon or ligament lesion

• Ultrasound or MRI assessment

• Lesion location and size documented

• A realistic prognosis

• A controlled rehabilitation plan

• Owner commitment to months of staged return-to-work

• A vet who can explain why stem cells are being chosen over other options

What About Osteoarthritis and Joint Disease?

Stem cell use in equine osteoarthritis is developing, but the evidence is more mixed and case-dependent.

A Veterinary Evidence review of mesenchymal stem cell therapy for equine osteoarthritis found weak to moderate evidence suggesting chondrogenically induced MSCs combined with allogeneic plasma can reduce short-term lameness in horses with mild to moderate osteoarthritis. However, the review found no definitive evidence that MSC therapy is more effective than intra-articular corticosteroids. (Veterinary Evidence)

That is the clinically important point.

Stem cells may be reasonable in some joint cases, but owners should not be told they are clearly better than all standard joint treatments.

In joint disease, treatment choice should consider:

• Which joint is painful

• Whether pain has been localised with diagnostic blocks

• Radiographic severity

• Whether there is cartilage, bone, meniscal, ligament, or synovial disease

• Whether corticosteroids are appropriate or risky

• Whether biologics such as PRP, IRAP, APS, or MSCs fit the case

• Competition rules

• Cost

• Expected duration of improvement

• Rehabilitation and workload adjustment

Stem cells may be part of an arthritis plan. They are not a replacement for diagnosis, farriery, weight management, controlled exercise, and realistic expectations.

Autologous vs Allogeneic Stem Cells

Stem cell therapies are often described as either autologous or allogeneic.

Type	What it means	Main advantages	Main concerns
Autologous	Cells come from the same horse being treated	Lower immune mismatch concern, patient-specific	Requires collection, processing time, variable cell quality
Allogeneic	Cells come from a donor horse	May be available faster, can be prepared in batches	Immune response, donor screening, product quality and regulation matter
Culture-expanded	Cells are grown in a lab to increase numbers	Allows more cells or repeated doses	Manufacturing quality, sterility, regulation and cell behaviour matter
Same-day processed	Cells are collected and processed more quickly	Faster treatment	Cell concentration and composition may vary

A 2024 Frontiers study of tenogenic-primed allogeneic peripheral blood-derived MSCs in horses with naturally occurring superficial digital flexor tendon and suspensory ligament injuries found no relevant hematologic or biochemical abnormalities after treatment in the small clinical safety arm, but the authors also listed major limitations, including small sample size and lack of statistical analysis in part of the study. (Frontiers)

So allogeneic therapy may be promising, but it should not be casually treated as risk-free or universally interchangeable with autologous treatment.

Regulation and Product Quality Matter

Stem cell products are not just “natural therapy.”

In the United States, the FDA states that cell-based products intended to diagnose, cure, mitigate, treat, or prevent disease, or affect the structure or function of an animal, generally meet the definition of a new animal drug and are regulated as such. FDA also states that there are currently no FDA-approved animal cell and tissue products for use in animals. (U.S. Food and Drug Administration)

The FDA warns that unapproved stem cell and other animal cell-based products may not meet standards for safety, effectiveness, manufacturing, or labelling. Reported safety concerns include disease transmission, contamination causing serious or life-threatening infection, inflammatory reactions, hypersensitivity reactions, anaphylaxis, and death. (U.S. Food and Drug Administration)

That does not mean every veterinary regenerative treatment is automatically unsafe. It means owners should ask hard questions about:

• Product source

• Sterility

• Donor screening

• Processing method

• Cell handling

• Storage and transport

• Regulatory status

• Evidence for that specific product

• Adverse event reporting

• Whether the treating vet has experience using it

A fancy brochure is not a quality-control program.

When Stem Cells May Be Worth Considering

Stem cells may be reasonable to discuss when:

• The horse has a confirmed tendon or ligament lesion

• The lesion carries a meaningful reinjury risk

• Imaging shows a structure that may benefit from regenerative support

• The horse is a valuable athlete or has a high functional goal

• The owner understands that rehab still takes months

• The treating vet can explain why stem cells are being chosen

• Other treatments are less suitable or have failed

• The product source and safety controls are clear

Examples where discussion may be reasonable include:

• Mid-body superficial digital flexor tendon core lesions

• Selected suspensory ligament injuries

• Selected mild to moderate joint disease where other options are unsuitable

• Focal cartilage or meniscal-associated injuries in specialist settings

• Cases where the goal is reducing reinjury risk, not instant return to work

The strongest argument for stem cells is usually not “faster healing.”

It is better quality healing and lower reinjury risk, especially in selected tendon cases.

When Stem Cells Are Less Likely To Help

Stem cells are less convincing when:

• No proper diagnosis has been made

• Lameness has not been localised

• Imaging has not confirmed a target lesion

• The injury is already chronic and heavily scarred

• The horse has advanced end-stage joint disease

• The horse has an active infection

• The horse has an undrained abscess

• A fracture is present or suspected

• There is severe laminitis

• The owner cannot commit to rehabilitation

• The treatment is being used as a last-minute attempt to avoid rest

• The main issue is poor hoof balance, poor conditioning, saddle fit, or workload mismatch

A stem cell injection into the wrong diagnosis is just an expensive way to avoid the real problem.

How Worried Should You Be?

Low Concern

This is more likely when:

• Stem cells are being discussed after a clear diagnosis

• The lesion has been imaged

• The treating vet explains the evidence and limitations

• Product source and sterility are clear

• Rehab expectations are realistic

• The horse is otherwise stable and not acutely worsening

Action: discuss options, compare costs and expected outcomes, and make a plan that includes imaging follow-up and staged rehabilitation.

Moderate Concern

This is more likely when:

• The horse has a chronic injury

• Imaging is incomplete

• The prognosis is unclear

• Several treatments are being combined

• The owner is being promised faster return to work

• The horse has multiple pain sources

• Cost is high and benefit is uncertain

Action: ask for a second opinion or referral review before committing.

High Concern

This is more likely when:

• Stem cells are being recommended without diagnostic imaging

• The treatment is marketed as a cure-all

• The product source is vague

• There is no sterile technique discussion

• Rehab is not part of the plan

• The horse is still very lame or worsening

• Infection, fracture, laminitis, or septic joint has not been ruled out

Action: pause. Get a proper diagnosis before treatment.

Critical

Treat this as urgent if:

• The horse is severely lame

• A joint is hot, swollen, and painful

• There is a wound near a joint or tendon sheath

• A tendon or ligament has acutely ruptured

• A fracture is possible

• The horse has fever or depression

• The horse becomes worse after injection

• There is severe swelling, pain, discharge, or systemic illness after treatment

Action: call your vet immediately. This is not a stem cell decision. This is a veterinary emergency.

When Is This an Emergency?

Stem cell therapy is never the first step in an emergency.

Call your vet urgently if your horse has:

• Sudden severe lameness

• Non-weight-bearing lameness

• A hot swollen joint

• Fever or depression

• A wound near a joint, tendon sheath, or deep structure

• Rapid swelling up a limb

• A dropped fetlock or suspected tendon rupture

• Severe pain after an injection

• Discharge, heat, swelling, or infection at an injection site

• Suspected fracture

• Acute laminitis signs

Regenerative therapy can wait. Emergency diagnosis cannot.

What Should Happen Before Stem Cell Treatment?

Before paying for stem cell therapy, the horse should have a proper workup.

That may include:

• Full history

• Lameness examination

• Hoof assessment

• Flexion tests

• Diagnostic nerve or joint blocks

• Ultrasound for tendon or ligament injuries

• Radiographs for joint or bone disease

• MRI or CT in selected complex cases

• Clear prognosis discussion

• Comparison with alternative treatments

• Written rehabilitation plan

• Recheck schedule

For tendon and ligament injuries, ultrasound is usually essential because it helps define the structure involved, lesion size, fibre disruption, and healing progression.

For joint disease, diagnostic blocks and imaging matter because joint injections should target the painful joint, not the joint everyone guessed was sore.

How Is Stem Cell Therapy Performed?

The exact process depends on the product and injury.

A typical plan may include:

1. Diagnosis and imaging
   The vet confirms the target lesion.

2. Cell source selection
   The cells may be autologous or allogeneic, and may come from bone marrow, fat, blood-derived sources, or other tissues.

3. Processing
   Cells may be concentrated, cultured, primed, combined with PRP, or prepared according to the product protocol.

4. Injection
   Tendon and ligament treatments are often performed ultrasound-guided into or around the lesion.

5. Rest period
   The horse usually needs strict controlled movement early.

6. Rehabilitation
   Progressive loading is introduced over weeks to months.

7. Rechecks
   Repeat ultrasound or other imaging guides progression.

8. Return to work
   Return is based on imaging, soundness, tissue healing, and workload goals.

The injection is the easy part.

The months after the injection are where the outcome is often won or lost.

Stem Cells vs PRP vs IRAP vs APS

Stem cells are only one type of regenerative therapy.

Therapy	Main idea	Common use
PRP	Concentrated platelets and growth factors	Tendon, ligament, joints in selected cases
IRAP or ACS	Anti-inflammatory proteins from processed blood	Joint inflammation and osteoarthritis
APS	Autologous protein solution with anti-inflammatory mediators	Joint disease in selected cases
Stem cells or MSCs	Cells that modulate repair and inflammation	Tendon, ligament, selected joints
Combination products	MSCs plus plasma or PRP	Some tendon, ligament, and joint protocols

The best choice depends on the diagnosis. “Regenerative” does not mean interchangeable.

A tendon core lesion, suspensory injury, coffin joint arthritis, and meniscal injury may all need different treatment logic.

Common Mistakes Owners Make

Believing “Stem Cells” Means One Standard Treatment

Source, processing, cell type, dose, timing, and delivery method all matter.

Expecting Regrowth Instead of Repair Support

Stem cells may help healing quality, but they do not guarantee perfect new tendon, ligament, or cartilage.

Skipping Imaging

You cannot treat a lesion properly if you do not know its size, location, and severity.

Forgetting Rehabilitation

Stem cells without rehab are like hiring a brilliant builder and never giving them plans, tools, or a worksite.

Returning to Work Too Early

The horse may look better before the tissue is strong enough for full load.

Treating Marketing as Evidence

If a company claims one product fixes joints, tendons, ligaments, backs, laminitis, wounds, and old age, step away from the glitter cannon.

Ignoring Infection Risk

Any injection into a tendon, ligament, joint, or sterile tissue space needs proper aseptic technique.

Not Asking About Regulation and Product Quality

Stem cell products vary. Product source, sterility, donor screening, and regulatory status matter.

What To Ask Your Vet Before Stem Cell Treatment

Ask these questions:

• What is the exact diagnosis?

• What imaging confirms it?

• Why are stem cells being recommended for this case?

• What type of cells are being used?

• Are they autologous or allogeneic?

• Where do the cells come from?

• Are they cultured or same-day processed?

• How are they tested for sterility and safety?

• What evidence supports this specific use?

• What are the alternatives?

• What happens if we do only rest and rehabilitation?

• What is the expected timeline?

• What are the risks?

• What is the recheck plan?

• What does success look like?

• What would make you stop or change the plan?

A good vet will not be offended by these questions. They are exactly the questions that should be asked.

What Does Recovery Look Like?

Recovery depends on the injury, not the injection.

A tendon or ligament injury may still require:

• Weeks of rest or restricted movement

• Hand walking

• Repeat ultrasound

• Gradual loading

• Months of controlled rehab

• Farriery support

• Careful return to ridden work

• Long-term monitoring for reinjury

A joint case may require:

• Short rest after injection

• Controlled return to exercise

• Weight management

• Farrier changes

• Ongoing arthritis management

• Repeat assessments

The biggest owner disappointment happens when stem cells are sold as a shortcut. They are not.

If anything, they make the rehabilitation plan more important because the goal is not just to get the horse comfortable. The goal is to guide tissue healing in the right direction.

Can Stem Cells Prevent Reinjury?

They may reduce reinjury risk in some tendon and ligament cases, but they do not make reinjury impossible.

The 2-year follow-up study of allogeneic tenogenic MSCs with PRP reported lower reinjury rates compared with conventional therapies in a literature-based comparison, but the study itself also acknowledged that non-blinded case series and literature-based comparisons are less conclusive than placebo-controlled, double-blinded clinical trials. (PMC)

That means the responsible message is:

Stem cells may reduce reinjury risk in selected cases, but workload, rehab, footing, conformation, farriery, lesion severity, and return-to-work timing still matter enormously.

No cell product overrides bad rehab.

Can Stem Cells Help Arthritis?

Sometimes, but expectations need to be realistic.

In mild to moderate osteoarthritis, some MSC therapies may improve lameness in the short term. However, evidence does not prove they are clearly better than corticosteroids, and they do not reliably reverse advanced cartilage loss. (Veterinary Evidence)

Stem cells may be more reasonable when:

• The arthritis is mild to moderate

• The horse has a clear painful joint

• Standard therapies are unsuitable or have limitations

• The owner understands cost and evidence limits

• The treatment is part of a broader arthritis plan

They are less convincing when:

• The joint is end-stage

• Bone-on-bone disease is present

• The horse has severe mechanical instability

• Farriery, weight, and workload are not being managed

• The owner expects permanent cartilage regrowth

Are Stem Cells Safe?

Stem cell therapy can be safe when performed properly, but risks exist.

Possible risks include:

• Infection

• Injection site pain

• Local inflammation

• Failure to improve

• Immune reaction, especially with some allogeneic products

• Product contamination

• Disease transmission with poorly controlled donor products

• Worsening lameness after injection

• Complications related to harvest, sedation, or processing

The FDA warns that unapproved animal cell and tissue products can carry risks including disease transmission, life-threatening infection from contamination, inflammatory reactions, hypersensitivity reactions, anaphylaxis, and death. (U.S. Food and Drug Administration)

This does not mean owners should fear every regenerative therapy. It means safety depends on product quality, sterility, case selection, and veterinary technique.

Prevention: Reducing the Need for Regenerative Treatment

You cannot prevent every tendon, ligament, or joint injury, but you can reduce risk.

Practical prevention includes:

• Build fitness gradually

• Avoid sudden workload spikes

• Maintain regular farrier care

• Keep hoof balance appropriate

• Avoid deep, slippery, or inconsistent footing

• Warm up properly

• Cool down properly

• Monitor legs after hard work

• Investigate small lameness early

• Do not train through heat, swelling, or tendon thickening

• Use rest days

• Maintain appropriate body weight

• Cross-train when possible

• Use repeat imaging after significant soft tissue injuries

• Return to work based on tissue healing, not calendar hope

Stem cells are not a substitute for good training management.

They are something you consider when the horse already has a meaningful injury.

Myth vs Reality

Myth	Reality
Stem cells regenerate perfect new tissue	They may help guide repair, but perfect regeneration is not guaranteed
Stem cells work for every injury	Evidence is strongest in selected tendon cases and more variable elsewhere
Stem cells replace rehabilitation	Rehab remains essential
All stem cell products are the same	Source, processing, donor status, culture method, dose, and quality control matter
Stem cells are always safer than corticosteroids	They have different risks and different evidence, and the best choice depends on the case
If stem cells are expensive, they must be better	Cost does not prove effectiveness
A stem cell injection means faster return to work	Many cases still require months of controlled rehabilitation

FAQs About Stem Cell Therapy in Horses

Are stem cells a cure for tendon injuries in horses?

No. Stem cells may help selected tendon injuries heal with better tissue organisation and potentially lower reinjury risk, but they do not remove the need for rest, imaging, controlled exercise, and gradual rehabilitation. (Veterinary Evidence)

Which horse injuries have the best evidence for stem cells?

The strongest practical support is for selected superficial digital flexor tendon injuries and some tendon or ligament lesions. Evidence for joint disease is developing, but it is more variable and case-dependent. (Veterinary Evidence)

Are stem cells better than PRP or IRAP?

Not automatically. PRP, IRAP, APS, and MSCs have different roles. The best option depends on the structure injured, disease stage, imaging findings, competition rules, cost, and veterinary judgement.

Are stem cell treatments FDA-approved for horses?

In the United States, the FDA states that there are currently no FDA-approved animal cell and tissue products for use in animals. Regulations vary by country, so owners should ask their veterinarian about the product’s regulatory status in their region. (U.S. Food and Drug Administration)

Should I get a second opinion before stem cell therapy?

A second opinion is sensible if the diagnosis is unclear, the cost is high, imaging has not been done, the horse is severely lame, or the treatment is being presented as a guaranteed fix.

The Bottom Line

Stem cell therapy in horses is promising, but it needs to be treated with scientific honesty.

The best evidence is not that stem cells are magic. The best evidence is that, in selected tendon and ligament injuries, they may improve repair quality and reduce reinjury risk when combined with proper diagnosis, imaging, and rehabilitation.

For arthritis, stem cells may help some horses with mild to moderate disease, but they are not clearly proven to outperform standard joint treatments, and they do not reliably reverse advanced degeneration.

The safest approach is simple:

• Diagnose the injury properly.

• Image the target structure.

• Ask what evidence supports stem cells for that exact condition.

• Understand the product source and safety controls.

• Compare alternatives.

• Budget for rehab, not just the injection.

• Return to work based on healing, not wishful thinking.

Stem cells may be part of the answer.

They should never be the whole plan.

---

If your horse has a tendon injury, ligament lesion, arthritis, or a confusing lameness case and you are unsure whether stem cells are worth considering, ASK A VET™ can help you organise the diagnosis, imaging findings, treatment options, and questions to discuss with your treating veterinarian.